Literature DB >> 28848893

The COPD Pipeline XXXII.

Nicholas Gross1.   

Abstract

Keywords:  ARALAST NP; AZD7624; BYM338; CK-2127107; COPD Cachexia; FDL169; GS5745; GSK2269557; Glassia; N91115; OligoG; Triple inhalers; VX-661; bimagrumab; ivacaftor

Year:  2016        PMID： 28848893      PMCID： PMC5556764          DOI： 10.15326/jcopdf.3.3.2016.0150

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  4 in total

1.  Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Authors:  Xiaolan Zhou; Jin Lin Wang; John Lu; Yanping Song; Keith S Kwak; Qingsheng Jiao; Robert Rosenfeld; Qing Chen; Thomas Boone; W Scott Simonet; David L Lacey; Alfred L Goldberg; H Q Han
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

Review 2.  A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD.

Authors:  Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera; Mario Cazzola
Journal:  Chest       Date:  2016-02-26       Impact factor: 9.410

Review 3.  Cystic fibrosis microbiology: Advances in antimicrobial therapy.

Authors:  Valerie Waters; Alan Smyth
Journal:  J Cyst Fibros       Date:  2015-02-28       Impact factor: 5.482

4.  Population PK-PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197.

Authors:  S De Buck; W Hueber; A Vitaliti; F Straube; C Emotte; G Bruin; R Woessner
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.